In The Press August 05, 2020

How the Biotech Capital Markets Are Faring in the Time of COVID-19 (MedCity News)

As we cross the mid-point of 2020, the second quarter turned out to be the busiest quarter for biotech equity to date. The recent uptick in activity following the COVID-19 pandemic has brought about some interesting trends during the 2020 IPO frenzy, that we expect to continue throughout the second half of 2020 and beyond shares Goodwin Technology and Life Sciences partner Seo Salimi. Read the MedCity News by-line here